| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_143ac4fbe1e063c6a828a96cfffc34d5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 |
| filingDate |
2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e081ee548340d78ad4670a142a6c2511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d663135f0c46801e18df65636045fd0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76b7e159477c09c88022e1c4990863c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6e3c9880e24c82bd4c67ad196ea57b0 |
| publicationDate |
2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202015662-A |
| titleOfInvention |
Pharmaceutical composition containing cilostazol and statin derivatives |
| abstract |
The present invention relates to a sustained-release combined preparation containing a statin-based drug which is an HMG-CoA reductase inhibitor and cilostazol as active ingredients, the sustained-release combined preparation includes an HMG-CoA reductase inhibitor mixed part containing an HMG-CoA reductase inhibitor and a cilostazol mixed part containing cilostazol, and the cilostazol mixed part includes immediate-release granules and sustained-release granules, and the sustained-release combined preparation has rapid pharmacological activity and less side effects and a sustained release to render a sufficient pharmacological effect by only one administration a day. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114533690-A |
| priorityDate |
2018-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |